Combination CGRP monoclonal antibody and onabotulinumtoxinA treatment for preventive treatment in chronic migraine

被引：19

作者：

Ailani, Jessica ^{[1
]}

Blumenfeld, Andrew M. ^{[2
]}

机构：

[1] MedStar Georgetown Univ Hosp, Dept Neurol, 3800 Reservoir Rd NW, Washington, DC 20007 USA

[2] Headache Ctr Southern Calif, Neurol Ctr, Carlsbad, CA USA

来源：

HEADACHE | 2022年 / 62卷 / 01期

关键词：

botulinum toxins type A; episodic migraine; headache; prevention;

D O I：

10.1111/head.14244

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：106 / 108

页数：3

共 10 条

[1] The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice [J].

Ailani, Jessica ;

Burch, Rebecca C. ;

Robbins, Matthew S. .

HEADACHE, 2021, 61 (07) :1021-1039

[2]

Boudreau GP., 2020, Anesth Pain Res, V4, P1, DOI [10.33425/2639-846x.1037, DOI 10.33425/2639-846X.1037]

[3] The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice [J].

Digre, Kathleen B. .

HEADACHE, 2019, 59 (01) :1-18

[4] Exploring the effects of extracranial injections of botulinum toxin type A on prolonged intracranial meningeal nociceptors responses to cortical spreading depression in female rats [J].

Melo-Carrillo, Agustin ;

Strassman, Andrew M. ;

Schain, Aaron J. ;

Noseda, Rodrigo ;

Ashina, Sait ;

Adams, Aubrey ;

Brin, Mitchell F. ;

Burstein, Rami .

CEPHALALGIA, 2019, 39 (11) :1358-1365

[5] Fremanezumab-A Humanized Monoclonal Anti-CGRP Antibody-Inhibits Thinly Myelinated (Aδ) But Not Unmyelinated (C) Meningeal Nociceptors [J].

Melo-Carrillo, Agustin ;

Strassman, Andrew M. ;

Nir, Rony-Reuven ;

Schain, Aaron J. ;

Noseda, Rodrigo ;

Stratton, Jennifer ;

Burstein, Rami .

JOURNAL OF NEUROSCIENCE, 2017, 37 (44) :10587-10596

[6] The Effect of Adding Calcitonin Gene-Related Peptide Monoclonal Antibodies to Onabotulinum Toxin A Therapy on Headache Burden: A Retrospective Observational Case Series [J].

Ozudogru, Seniha N. ;

Bartell, Jared W. ;

Yuan, Heidi ;

Digre, Kathleen B. ;

Baggaley, Susan K. .

HEADACHE, 2020, 60 (07) :1442-1443

[7] Dual Therapy With Anti-CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale? [J].

Pellesi, Lanfranco ;

Do, Thien P. ;

Ashina, Hakan ;

Ashina, Messoud ;

Burstein, Rami .

HEADACHE, 2020, 60 (06) :1056-1065

[8] FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine [J].

Rothrock, John F. ;

Adams, Aubrey Manack ;

Lipton, Richard B. ;

Silberstein, Stephen D. ;

Jo, Esther ;

Zhao, Xiang ;

Blumenfeld, Andrew M. .

HEADACHE, 2019, 59 (10) :1700-1713

[9] Migraine pathophysiology and its clinical implications [J].

Silberstein, SD .

CEPHALALGIA, 2004, 24 :2-7

[10] Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial [J].

Tepper, Stewart ;

Ashina, Messoud ;

Reuter, Uwe ;

Brandes, Jan L. ;

Dolezil, David ;

Silberstein, Stephen ;

Winner, Paul ;

Leonardi, Dean ;

Mikol, Daniel ;

Lenz, Robert .

LANCET NEUROLOGY, 2017, 16 (06) :425-434

← 1 →